• 1. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 2. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 3. An intermolecular C–H oxidizing strategy to access highly fused carbazole skeletons from simple naphthylamines?
  Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752
• 4. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

Exploring (2R)-2-amino-5-cyclopropylpentanoic acid (CAS No. 1998643-64-3): Properties, Applications, and Market Insights

The compound (2R)-2-amino-5-cyclopropylpentanoic acid (CAS No. 1998643-64-3) is a specialized amino acid derivative that has garnered significant attention in pharmaceutical and biochemical research. This enantiomerically pure compound is characterized by its unique cyclopropyl side chain, which imparts distinct steric and electronic properties. Researchers are increasingly interested in this molecule due to its potential role in drug discovery, particularly in the development of novel enzyme inhibitors and peptide-based therapeutics.

From a structural perspective, (2R)-2-amino-5-cyclopropylpentanoic acid features a chiral center at the 2-position (R-configuration) and a cyclopropyl group at the terminal end of its pentanoic acid backbone. This configuration makes it particularly valuable for studying structure-activity relationships in medicinal chemistry. The cyclopropyl moiety is known to enhance metabolic stability while maintaining favorable pharmacokinetic properties, making derivatives of this compound attractive candidates for pharmaceutical development.

The synthesis of CAS 1998643-64-3 typically involves asymmetric synthesis routes to ensure the desired (R)-configuration. Recent advances in chiral catalysis have improved the efficiency of producing this compound at scale, addressing one of the key challenges in its commercial availability. Analytical characterization of this material generally employs techniques such as chiral HPLC, mass spectrometry, and NMR spectroscopy to verify both purity and stereochemical integrity.

In pharmaceutical applications, (2R)-2-amino-5-cyclopropylpentanoic acid serves as a valuable building block for peptide modification. Its incorporation into peptide sequences can significantly alter the conformational properties of the resulting molecules, potentially enhancing target binding affinity or improving proteolytic stability. This has become particularly relevant in the development of peptide therapeutics, which represent one of the fastest-growing segments in the biopharmaceutical market.

Beyond drug development, this compound finds utility in biochemical research as a tool for studying enzyme-substrate interactions. The constrained geometry of the cyclopropyl group provides researchers with a unique probe for investigating active site flexibility in various enzymes. Recent publications have highlighted its use in understanding the mechanism of amino acid-processing enzymes, contributing to fundamental knowledge in enzymology.

The market for specialty amino acids like (2R)-2-amino-5-cyclopropylpentanoic acid has seen steady growth, driven by increasing demand from both academic and industrial research sectors. Suppliers typically offer this compound in research quantities, with purity grades ranging from 95% to 99% for different applications. Current pricing reflects its status as a specialty chemical, though costs have become more competitive as synthetic methods have improved.

Storage and handling of CAS 1998643-64-3 require standard precautions for amino acid compounds. The material is generally stable at room temperature when protected from moisture and light. For long-term storage, refrigeration under inert atmosphere is recommended to maintain optimal stability, particularly for high-purity grades intended for sensitive applications.

Recent trends in chemical research have increased interest in constrained amino acid analogs like (2R)-2-amino-5-cyclopropylpentanoic acid. The growing focus on peptide-based drugs and the need for metabolically stable analogs in medicinal chemistry have positioned this compound as an important research tool. Its applications in developing new therapeutic candidates continue to expand as researchers explore its potential in various drug discovery programs.

Quality control for (2R)-2-amino-5-cyclopropylpentanoic acid typically involves multiple analytical techniques to ensure both chemical and chiral purity. Batch-to-batch consistency is particularly important for research applications where reproducible results are essential. Leading suppliers now provide comprehensive analytical data with each lot, including chromatograms and spectroscopic evidence of structure confirmation.

The future outlook for CAS 1998643-64-3 appears promising, with potential applications emerging in areas such as targeted drug delivery and diagnostic probe development. As synthetic methodologies continue to advance, the accessibility of this and related constrained amino acids is expected to improve, further driving research utilization across multiple scientific disciplines.

For researchers working with (2R)-2-amino-5-cyclopropylpentanoic acid, proper characterization of reaction products incorporating this building block is essential. The unique spectroscopic signatures of the cyclopropyl group can serve as valuable markers for reaction monitoring and product verification. This aspect has made the compound particularly useful in methodological development studies within organic chemistry.

Environmental and safety considerations for CAS 1998643-64-3 follow standard protocols for amino acid derivatives. While not classified as hazardous, proper laboratory practices should be maintained when handling the compound. Material safety data sheets provided by manufacturers contain detailed information about appropriate handling procedures and personal protective equipment recommendations.

The scientific literature continues to document new applications for (2R)-2-amino-5-cyclopropylpentanoic acid, particularly in the design of conformationally constrained peptides. Recent studies have demonstrated its utility in creating secondary structure mimics and stabilizing particular peptide conformations. These developments underscore the compound's versatility as a research tool in both academic and industrial settings.

As the field of peptide therapeutics expands, the demand for specialized amino acid building blocks like (2R)-2-amino-5-cyclopropylpentanoic acid is expected to grow correspondingly. The compound's unique structural features position it well for addressing current challenges in peptide drug development, including stability enhancement and bioavailability improvement. This trend aligns with broader movements in pharmaceutical research toward more targeted and specific therapeutic agents.

In conclusion, (2R)-2-amino-5-cyclopropylpentanoic acid (CAS No. 1998643-64-3) represents a valuable tool for researchers across multiple disciplines. Its unique structural properties, combined with growing applications in drug discovery and biochemical research, ensure its continued relevance in scientific investigation. As synthetic methods advance and new applications emerge, this specialized amino acid derivative is poised to play an increasingly important role in cutting-edge research and development efforts.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)